Table 2. Baseline Laboratory Characteristics of Participants According to Gender.
Investigation | Total | Male | Female | P-value |
Hemoglobin** | 10.73 ± 0.185 | 11.12 ± 0.26 | 10.25 ± 0.24 | 0.02 |
TLC* | 13.9 (11.8 IQR) | 13.9 (10.80) | 13.9 (11.50) | 0.30 |
Neutrophils* | 84.0 (13.2) | 84.90 (10.75) | 84.10 (13.90) | 0.30 |
Lymphocytes* | 8.0 (10.05 IQR) | 8.0 (9.10) | 8.3 (11.00) | 0.55 |
NLR* | 10.59 (13.5 IQR) | 10.75 (13.07) | 9.70 (13.60) | 0.43 |
Platelets* | 229 (161 IQR) | 201 (117) | 257 (202) | 0.04 |
Creatinine* | 1.80 (2.48 IQR) | 1.80 (2.45) | 1.70 (2.40) | 0.59 |
Total bilirubin* | 0.60 (0.80 IQR) | 0.70 (0.50) | 0.50 (0.90) | 0.05 |
Lactate* | 2.00 (1.50 IQR) | 2.0 (1.45) | 1.9 (1.55) | 0.27 |
PaO2/FiO2* | 364 (166 IQR) | 361 184.6) | 371 (153.0) | 0.50 |
CRP* | 105 (158.9 IQR) | 98.25 (158.3) | 107 (133.7) | 0.70 |
Procalcitonin* | 1.38 (12.35 IQR) | 3.39 (14.05) | 0.80 (6.30) | 0.04 |